These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10708959)

  • 1. TGF-beta in diabetic kidney disease: role of novel signaling pathways.
    Sharma K; McGowan TA
    Cytokine Growth Factor Rev; 2000; 11(1-2):115-23. PubMed ID: 10708959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lovastatin inhibits transforming growth factor-beta1 expression in diabetic rat glomeruli and cultured rat mesangial cells.
    Kim SI; Han DC; Lee HB
    J Am Soc Nephrol; 2000 Jan; 11(1):80-87. PubMed ID: 10616843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-beta-induced fibronectin in mesangial cells.
    Isono M; Chen S; Hong SW; Iglesias-de la Cruz MC; Ziyadeh FN
    Biochem Biophys Res Commun; 2002 Sep; 296(5):1356-65. PubMed ID: 12207925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The key role of the transforming growth factor-beta system in the pathogenesis of diabetic nephropathy.
    Chen S; Hong SW; Iglesias-de la Cruz MC; Isono M; Casaretto A; Ziyadeh FN
    Ren Fail; 2001; 23(3-4):471-81. PubMed ID: 11499562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria.
    Wang A; Ziyadeh FN; Lee EY; Pyagay PE; Sung SH; Sheardown SA; Laping NJ; Chen S
    Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1657-65. PubMed ID: 17804483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressions of chronic glomerular injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy.
    Mizuno S; Nakamura T
    Am J Physiol Renal Physiol; 2004 Jan; 286(1):F134-43. PubMed ID: 14519594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
    Lee EA; Seo JY; Jiang Z; Yu MR; Kwon MK; Ha H; Lee HB
    Kidney Int; 2005 May; 67(5):1762-71. PubMed ID: 15840023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator.
    Sharma K; Ziyadeh FN
    Diabetes; 1995 Oct; 44(10):1139-46. PubMed ID: 7556948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy.
    Yamamoto T; Nakamura T; Noble NA; Ruoslahti E; Border WA
    Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1814-8. PubMed ID: 7680480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of TGF-beta type II receptor by high glucose in mouse mesangial cells and in diabetic kidney.
    Isono M; Mogyorósi A; Han DC; Hoffman BB; Ziyadeh FN
    Am J Physiol Renal Physiol; 2000 May; 278(5):F830-8. PubMed ID: 10807596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tranilast prevents the progression of experimental diabetic nephropathy through suppression of enhanced extracellular matrix gene expression.
    Akahori H; Ota T; Torita M; Ando H; Kaneko S; Takamura T
    J Pharmacol Exp Ther; 2005 Aug; 314(2):514-21. PubMed ID: 15857946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of transforming growth factor-beta in regulation of calcium transients in diabetic vascular smooth muscle cells.
    Sharma K; Deelman L; Madesh M; Kurz B; Ciccone E; Siva S; Hu T; Zhu Y; Wang L; Henning R; Ma X; Hajnoczky G
    Am J Physiol Renal Physiol; 2003 Dec; 285(6):F1258-70. PubMed ID: 12876066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of diabetic nephropathy in rats by prostaglandin E receptor EP1-selective antagonist.
    Makino H; Tanaka I; Mukoyama M; Sugawara A; Mori K; Muro S; Suganami T; Yahata K; Ishibashi R; Ohuchida S; Maruyama T; Narumiya S; Nakao K
    J Am Soc Nephrol; 2002 Jul; 13(7):1757-65. PubMed ID: 12089371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular basis of diabetic nephropathy: II. The transforming growth factor-beta system and diabetic nephropathy lesions in type 1 diabetes.
    Huang C; Kim Y; Caramori ML; Fish AJ; Rich SS; Miller ME; Russell GB; Mauer M
    Diabetes; 2002 Dec; 51(12):3577-81. PubMed ID: 12453917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory smads and tgf-Beta signaling in glomerular cells.
    Schiffer M; Schiffer LE; Gupta A; Shaw AS; Roberts IS; Mundel P; Böttinger EP
    J Am Soc Nephrol; 2002 Nov; 13(11):2657-66. PubMed ID: 12397035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced TGF-beta/Smad signaling in the early stage of diabetic nephropathy is independent of the AT1a receptor.
    Okazaki Y; Yamasaki Y; Uchida HA; Okamoto K; Satoh M; Maruyama K; Maeshima Y; Sugiyama H; Sugaya T; Kashihara N; Makino H
    Clin Exp Nephrol; 2007 Mar; 11(1):77-87. PubMed ID: 17385003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy.
    Wang SN; LaPage J; Hirschberg R
    Kidney Int; 2000 Mar; 57(3):1002-14. PubMed ID: 10720953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of Shenkangwan on mesangial cell NO and TGF-beta1 excretion in rats with early diabetic nephropathy].
    Chen GB; Wei LB; Xiao W; Long HB
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Apr; 26(4):526-8. PubMed ID: 16624774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse.
    Hong SW; Isono M; Chen S; Iglesias-De La Cruz MC; Han DC; Ziyadeh FN
    Am J Pathol; 2001 May; 158(5):1653-63. PubMed ID: 11337363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway.
    Wang D; Zhang G; Chen X; Wei T; Liu C; Chen C; Gong Y; Wei Q
    Int J Mol Med; 2018 May; 41(5):2784-2792. PubMed ID: 29484381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.